Recruiting Tuberous Sclerosis Studies in Palo Alto
About Tuberous Sclerosis Clinical Trials in Palo Alto
Tuberous sclerosis complex is a rare genetic disease that causes non-cancerous tumors to grow in many parts of the body including the brain, kidneys, heart, and skin. Symptoms vary widely depending on tumor location. Treatment includes mTOR inhibitors and management of specific symptoms.
There are currently 1 tuberous sclerosis clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 64 participants. Research is being sponsored by Darcy Krueger. Clinical trial participation is free and participants receive study-related medical care at no cost.
Tuberous Sclerosis Clinical Trials in Palo Alto — FAQ
Are there tuberous sclerosis clinical trials in Palo Alto?
Yes, there are 1 tuberous sclerosis clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What tuberous sclerosis treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for tuberous sclerosis.
Data updated March 2, 2026 from ClinicalTrials.gov